Genetic and lifestyle predictors of ischemic stroke severity and outcome
Different models that include clinical variables and blood markers have been investigated to predict acute ischemic stroke treatment course and recovery.
The aim of the study was to investigate associations between lipid levels, lifestyle factors, hemostatic (F5, F2, SERPINE1, F13A1, and FGB), and atherogenic (APOA5 and ACE) gene variants and acute ischemic stroke (AIS) severity.
Materials and methods
This study included 250 patients with AIS in which F5, F2, SERPINE1, F13A1, FGB, APOA5, and ACE genotypes were determined. Total cholesterol (TC), high-density cholesterol, low-density cholesterol, and triglycerides concentrations were measured within 24 h of the AIS onset. Examination of the neurological deficit was done using National Institutes of Health Stroke Scale/Score (NIHSS).
APOA5 genotype [TC + CC] was more frequent (P = 0.026) in patients with the NIHSS score ≥ 21. Univariate regression analysis has shown that triglycerides (OR 0.55, 95% CI 0.34–0.91; P = 0.019), obesity (0.28, 95% CI 0.10–0.73; P = 0.010), age (OR 1.08, 95% CI 1.04–1.13; P < 0.001), and APOA5 genotype (TC + CC) (OR 2.40, 95% CI 1.10–5.25; P = 0.034) are significantly associated with a severe stroke. When all variables were included in model age (OR 1.06, 95% CI 1.01–1.11; P = 0.018), obesity (OR 0.25, 95% CI 0.08–0.77; P = 0.016) and APOA5 genotype (TC + CC) (OR 3.26, 95% CI 1.29–8.23; P = 0.012) remained significant for the risk of severe AIS.
APOA5 genotype (TC + CC), age, and obesity could be used as prognostic risk factors for a very severe stroke (NIHSS ≥ 21).
KeywordsAPOA5 variant Stroke severity Risk factors Triglycerides
Compliance with ethical standards
Sestre milosrdnice University Hospital Center ethics committee approved the study and all participants signed informed consent.
Conflict of interest
The authors declare that they have no conflict of interest.
- 15.Tasdemir S, Erdem HB, Sahin I, Ozel L, Ozdemir G, Eroz R, Tatar A (2016) Correlation with platelet parameters and genetic markers of thrombophilia panel (factor II g.20210G>A, factor V Leiden, MTHFR (C677T, A1298C), PAI-1, β-fibrinogen, factor XIIIA (V34L), glycoprotein IIIa (L33P)) in ischemic strokes. NeuroMolecular Med 18:170–176PubMedGoogle Scholar
- 17.Atadzhanov M, Mwaba MH, Mukomena PN, Lakhi S, Rayaprolu S, Ross OA et al (2013) Association of the APOE, MTHFR and ACE genes polymorphisms and stroke in Zambian patients. Neurol Int 5:69–72Google Scholar
- 19.Malueka RG, Dwianingsih EK, Sutarni S, Bawono RG, Bayuangga HF, Gofir A et al (2017) The D allele of the angiotensin-converting enzyme (ACE) insertion/deletion (I/D) polymorphism is associated with worse functional outcome of ischemic stroke. Int J Neurosci 7454:1–21Google Scholar
- 23.Fonarow GC, Saver JL, Smith EE, Broderick JP, Kleindorfer DO, Sacco RL, Pan W, Olson DM, Hernandez AF, Peterson ED, Schwamm LH (2012) Relationship of National Institutes of Health Stroke scale to 30-day mortality in Medicare beneficiaries with acute ischemic Stroke. J Am Heart Assoc 1:42–50PubMedPubMedCentralGoogle Scholar
- 24.Ver HA (2011) The NIH stroke scale: a window into neurological status. Nursing Spectrum (Greater Chicago) 24:44–49Google Scholar
- 42.Roach REJ, Roshani S, Meijer K, Hamulyák K, Lijfering WM, Prins MH, Büller HR, Middeldorp S (2011) Risk of cardiovascular disease in double heterozygous carriers and homozygous carriers of F5 R506Q (factor V Leiden) and F2 (prothrombin) G20210A: a retrospective family cohort study. Br J Haem 153:134–136Google Scholar
- 44.Herm J, Hoppe B, Siegerink B, Nolte CH, Koscielny J, Haeusler KG (2017) A prothrombotic score based on genetic polymorphisms of the hemostatic system differs in patients with ischemic stroke, myocardial infarction, or peripheral arterial occlusive disease. Front Cardiovasc Med 4:39PubMedPubMedCentralGoogle Scholar